2m 2m 2m 2m 2m 2m 2m
XTL BIOPHARM SP ADR (XTLB)
NASDAQ
$1.63-$0.03 (-1.75%)
Price as of Nov 12, 2026 8:10 AM EST- $4.1MMarket Cap
- -57.22%1-Year Change
- BiotechnologyIndustry
XTL BIOPHARM SP ADR (XTLB)
$1.63-$0.03 (-1.75%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
NOKED CAPITAL LTD | 2.10% | 198,888 | 0 (0.00%) | Sep 30, 2022 |
RENAISSANCE TECHNOLOGIES LLC | 0.25% | 23,280 | +1,000 (+4.30%) | Dec 31, 2021 |
RHUMBLINE ADVISERS | 0.07% | 6,871 | +643 (+9.36%) | Sep 30, 2026 |
GAMMA INVESTING LLC | 0.01% | 1,213 | -2,175 (-179.31%) | Jun 30, 2026 |
UBS GROUP AG | 0.005% | 427 | +302 (+70.73%) | Sep 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.02% | 1,439 | -786 (-54.62%) | Aug 31, 2026 |
Current Ownership Distribution
- Insiders44.9M (89.50%)
- Institutions5.1M (10.18%)
- Mutual Funds156,403 (0.31%)
- Other0 (0.00%)
Insider Transactions
- 89.50% (44.9M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
No data found